VITAMIN D METABOLISM Skin
Solar ultraviolet radiation will photolyse 7-dehydrocholesterol (provitamin D 3 ) in the skin to previtamin D 3 • Previtamin D 3 forms vitamin D 3 (cholecalciferolj'F by a time (2-3 days) and temperature dependent isomerisation. Continued exposure to sunlight results in the formation of biologically inert products; previtamin D 3 is photoisomerized to lumesterol and tachysteroland vitamin D 3 is photodegraded to 5,6-transvitamin D] and suprasterols I and 2 (Fig. 1 ).4 Melanin, by absorbing UV radiation, may also partly limit formation of previtamin D 3 .s Thus, sunlight regulates the production of previtamin D] and vitamin D] and limits the systemic availability of vitamin D].
Liver
Although synthesis by the skin is the more important source of vitamin D, the normally low dietary intake of vitamin D 2 (ergocalciferol) and vitamin D] may be critical when exposure to sunlight is lacking. Cholecalciferol arising in the skin becomes bound to vitamin D binding protein (DBP) and together with dietary ergocalciferol and cholecalciferol (incorporated into chylomicrons) is transported to the liver where hydroxylation occurs to yield 25 hydroxyvitamin D [25(OH)VitD,calcidiol] ,6,7 the main circulating form of vitamin D. Plasma concentrations of 25(OH)VitD reflect vitamin D status derived from both endogenous and exogenous sources. In the UK a marked seasonal This article was commissioned by the Clinical Laboratory Investigations Subcommittee of the Scientific Committee of the Association of Clinical Biochemists.
Correspondence: Dr S J Iqbal. variation in concentration occurs, the lowest levels occurring around March and the highest levels around September. 8 The liver also has a role in catabolizing vitamin D. Although an enterohepatic circulation of vitamin D metabolites exists in man it is probably of little significance in conserving vitamin D.9
Kidney Further hydroxylation of calcidiol to the systemically active hormonal metabolite, 1,25dihydroxyvitamin D [I ,25(OH)2VitD, calcitriol] , takes place in the kidney;" This hydroxylation is closely regulated. Calcitriol production is stimulated by parathormone (PTH) and hypophosphataemia and inhibited by hyperphosphataemia!' and calcitriol itself. In vitro, varying calcium concentration may influence I-a hydroxylase activity. 12 However, this effect, independently of the effects of PTH, has not been convincingly demonstrated in vivo. I] Other hormones, including growth hormone, prolact~, oestrogen, glucocorticoids, insulin and thyroid hormone may modulate calcitriol production.
The kidney also produces 24,25 dihydroxyvitamin D [24, 25(OH) 2 VitD] ; there are conflicting reports concerning the significance of the biological activity of this metabolite.lv'! Other renal metabolites of vitamin D have also been described but the significance of actions of these is unclear.
Extra-renal production of 1,25(OHh VitD The placenta also possesses lo-hydroxylase activity, which accounts for the increased levels of calcitriol found in pregnancy. 16 In vitro, cultured keratinocytes'? and bone cells" have been shown to produce calcitriol. Pulmonary alveolar macrophages from patients with sarcoidosis have been shown to produce calcit rioI from calcidiol,'? and the uncontrolled production of the active metabolite in this condition and other granulomatous diseases is thought to mediate the hypercalciuria and/or hypercalcaemia that may occur in these disorders. In vitro, sarcoid macrophage lo hydroxylation has been shown to be stimulated by interferon ' Y (lFN·'Y) and inhibited by dexamethosone, whilst PTH and calcitriol had no effect.!? l,2S-DiHYDROXYVITAMIN D;
MECHANISMS OF ACTION AND TARGET TISSUES
In its target cells calcitriol interacts with its receptor protein (vitamin D receptor; VDR) and facilitates the binding of VDR to an uncharaeterized protein-nuclear accessory factor (NAF). In the presence of calcitriol the heterodimer protein (VDR-NAF) interacts with DNA at the vitamin D response element sites (VDRE) to control transcription of calcitrioldependent genes (Fig. 2 ). 20 The VDREs for the human osteocalcin gene have been sequenced.
Some of the rapid 'non-genomic' actions of calcitriol, including the elevation of cyclic guanosine monophosphate (cGMP) may be VDRmediated." VDR has a wide tissue distribution13.22 and the possibility of two different types of VDR corresponding to the classical and non-classical site has been suggested." In some cells VDR levels may be regulated by calcitriol. 24 The primary amino acid sequence of chick" and human intestinal" VDR has been deduced. The VDR protein has separate functional domains. The DNA-binding domain of VDR, at the amino terminal end, has two dissimilar fingerlike projections anchored by zinc atoms ('zinc fingers'). This part of the molecule is highly conserved and exhibits strong homology with other steroid receptors showing that it belongs to the steroid receptor 'superfamily'. The carboxyterminal portion of VDR binds catcitriol.!' Several genes have been identified that are regulated by calcitriol ( Fig. 2 Calcitriol may also mediate some of its action by increasing intracellular calcium which has been shown to occur in terminally differentiating keratinocytes-? via the phosphoinositol pathway.
Intestine
One of the most important actions of calcitriol is to stimulate intestinal calcium absorption by a genomic up-regulation of the production of a calcium-binding protein (CaBP; Calbindin D): 30, 31 CaBPs, including calmodulin, are found in a number of tissues and probably have a common ancestral gene. The production of renal CaBP appears to be vitamin D dependent whereas, say, in the cerebellum CaBP production is probably vitamin D independent.I! In addition, intestinal calcium absorption by calcitriol may be mediated by a non-genomic mechanism.F Calcitriol also promotes phosphate absorption from the small intestine." Bone Calcitriol promotes bone mineralization indirectly by provision of calcium and phosphorus. In vitro a variety of effects on bone cells have been demonstrated. Receptors for calcitriol are present on osteoblasts; in response to exposure to calcitriol, these cells increase the production of alkaline phosphatase;" osteocalcin.P and down-regulate the production of type I collagen. 36 Calcitriol mediates osteoclastic bone resorption indirectly since these cells lack calcitriol receptors. Calcitriol stimulates osteoblasts to produce an as yet uncharacterized factor [osteoclastic resorption stimulating activity (ORSA)] and neutral proteases. ORSA stimulates osteoclastic bone resorption and the neutral proteases digest the unmineralized bone surface." The exposed mineral induces previously inactive osteoclasts into resorptive activity. In addition calcitriol induces the differentiation of osteoclasts from haemopoietic precursors ( Fig. 3 ).37
Kidney
Calcitriol inhibits its own production by suppressing 1a-hydroxylase activity" and stimulates 24-hydroxylase activity. Calcitriol may have a permissive role in the phosphaturic effect Iqbal FIGURE 4. Parathormone and calcitriol reciprocally influence each other's production indirectlyby alteration in extracellular calcium and phosphate levels. There is also direct reciprocal regulation ofproduction of these hormones.
of PTH and may influence calcium handling by the kidney.
Parathyroid glands
In vitro and in vivo studies have shown calcitriol to be a powerful inhibitor of PTH productlon.rv'" Calcitriol reduces PTH secretion directly by inhibiting transcription of preoproparathyroid hormone.r" and indirectly by increasing serum calcium levels. PTH and calcitriol have direct regulatory effects on each other, thus forming an important overall control loop in the maintenance of calcium and phosphorus homeostasis ( Fig. 4 ).
Lymphocytes, macrophages and monocytes Activated macrophages are able to produce calcitriol and regulate its levels in the immune microenvironment independently of its systemic circulating concentration." This supports an autocrine and paracrine role for calcitriol in immunomodulation. Activated lymphocytes and monocytes express VDR 4 1 and calcitriol inhibits some of the lymphokines produced by activated T cells including interleukin-2 (IL-2),42 interferon-v (IFN-'Y)43 and granulocyte-macrophage colonystimulating factor (GMC).44 Calcitriol may influence maturation and differentiation of T lymphocytes in the thymus, while peripheral T cell proliferation is inhibited probably by inhibition of IL-2 production." Calcitriol inhibits immunoglobulin production by B cells" both directly and indirectly through its effect on T helper cells."
Calcitriol influences monocyte and macrophage function by increasing production of some of the cytokines including tumour necrosis factor (TNF), prostaglandin E 2 (PGE:z) and IL-l all of which induce bone resorption." This paracrine effect of calcitriol may augment its recognized endocrine role in bone metabolism. Overall calcitriolincreases the multinuclearity, cytoxicity, chemotactic activity and heat stability of the monocyte/ macrophage during the inflammatory response."
Malignant tissue
The inhibitory effects of calcitriol on cancer cell growth was initially shown in melanoma.v Subsequent in vivo and in vitro studies have shown that calcitriol influences a variety of malignant tissue, including carcinoma of breast, lung, pancreas, colon, bladder and ovary as well as leukaemic cells and malignant melanoma cells (Table 1) .28,46 A recent study has shown a protective effect of calcidiol on the development of colonic cancer." Calcitriol has been shown to influence the differentiation of murine leukaemic cells towards macrophage phenotype'" and similar effects have been shown in harvested human leukaemic cells.t? Such observations has led to the trial use of calcipitriol, an analogue of calcitriol, in the treatment of advanced breast cancer r" Suggested mechanisms by which calcitriol may influence cellular growth and differentiation in malignant and other cells include modification of intracellular calcium'? 
PATHOPHYSIOLOGY OF DISTURBED VITAMIN D METABOLISM
Hypovitaminosis D Hypovitaminosis D may arise as a result of deficient production, intake, absorption or Other tissues Calcitriol has been shown to have effects on a variety of other tissues (see Table 1 ) including the pituitary, pancreas, cardiac and skeletal muscle cells, the thyroid gland and the gonads." metabolism. Resistance to Vitamin D leads to apparent hypovitaminosis D ( Fig. 5 ).
Privational (nutritional) vitamin D deficiency
Although rickets was common earlier this century, it largely disappeared in the 1940s. The early 1960ssaw the resurgence of privational vitamin D deficiency in the UK, primarily in Asian immigrants," and this problem may still persist. 56, 57 Aetiological mechanisms include lack of exposure to sunlight, excessive cereal in the diet;" and vegetarianism. 59 A low calcium, high cereal diet may also induce mild secondary hyperparathyroidism, which enhances the catabolism of vitamin D, and this may exacerbate the vitamin D deficiency.s?
Privational vitamin D deficiency also affects the elderly." Evidence as to how much it contributes to the high incidence of femoral neck fractures remains unclear. 62 Immobility and the reduced vitamin D synthetic capacity of the skin in the elderly may exacerbate their poor dietary intake. [63] [64] [65] The increased liability of elderly to fracture bones is probably multifactorial; the reduction in bone mineral density with age, especially in postmenopausal women, compromised vitamin D status and declining renal function with impaired l o-hydroxylatlon and resulting secondary hyperparathyroidism's are all probably contributory.
The use of certain topical sunscreens may also limit cutaneous synthesis of vitamin D 3.67 Seasonal and latitudinal shifts in the spectral characteristics of solar radiation means that at some latitudes in winter months not only is vitamin D poorly synthesized, but its catabolism is enhanced.P
Gastrointestinal and hepatobiliary disease
Gastrointestinal abnormalities causing significant malabsorption will tend to produce hypovitaminosis D. This is the mechanism for the development of osteomalacia in some patients years after partial gastrectomy.69 Biliary disease is often associated with significant vitamin D malabsorption. However, even in extensive hepatocellular disease vitamin D deficiency is uncommon, although circulating levelsof calcitriol may be lower because of reduced synthesis of binding protein." Selective deficiency of 25-hydroxylase in the liver has not been described. However, premature infants may be poor at absorbing and/or converting vitamin D to 25(OH)VitD.71 Increased catabolism of 25(OH)VitD may be important in producing or enhancing vitamin D deficiency in primary and secondary hyperparathyroid states. 60 and of oncogene expression." In vitro studies have shown that, in some cell types, expression of VDR paralleled the production of mRNA on the oncogene C-myc. The protein encoded by the C-myc oncogene may influence the cellular transcription apparatus and thus affect genes whose products are important for cell growth and differentiation.!' It has also been suggested that calcitriol, interacting via its VDR, may provide a negative feedback signal and inhibit oncogenedriven cell proliferation and differentiation. The prodifferentiation effects of calcitriol in promyelocytic leukaemic cells are preceded by a striking decrease in expression of C-myc. 52
Skin Skin, as well as being a major source of vitamin D, is also a target tissue for calcitriol. When exposed to calcitriol, cultured human keratinocytes show a decrease in proliferation and an increase in terminal differentiation.53 Thus, topical calcitriol and its analogue calcipitriol have been used successfully for treating psoriasis. 54 
Anticonvulsant treatment
Anticonvulsant therapy is sometimes associated with bone disease which results from the induction of hepatic microsomal enzymes involved in vitamin D catabolism73 and subsequent production of inactive metabolites. A direct effect to reduce intestinal calcium absorption may also be important. 74 Biochemical pathophysiology of uraemic osteodystrophy Uraemic osteodystrophy has become increasingly common with improved treatment of chronic renal failure. 75 The deficient production of calcitriol is of central importance but other contributory factors include phosphate retention, hypocalcaemia, hyperparathyroidism, and metabolic acidosis;" Various forms of therapy such as a control of hyperphosphataemia, use of l o analogues of vitamin D, dialysis, transplantation and parathyroidectomy may complicate the picture." Calcitriol production appears to be impaired early in renal failure"? and this may be due more to suppressive effects of phosphate retention on la-hydroxylation than to an intrinsic renal effect;" since restriction of phosphate intake even in the absence of hyperphosphataemia can restore calcitriol production to normal.77 Raised levels of PTH are detectable at an early stage 75 and an effect of PTH on bone is demonstrable by the time the GFR has fallen by 5011,10. 76 The availability of intact PTH measurements should lead to a better understanding of secondary hyperparathyroidism in this situation." Calcitriol appears to have a direct suppressive effect on pre-proparathyroid hormone production.s'' Falling levels of calcitriol therefore may be most important in initiating secondary hyperparathyroidism (supported by findings of relative hypophosphataemialb'" in very early renal failure due to the phosphaturic effect of PTH). la analogues enhance phosphate absorption and may produce hypercalcaemia which may lead to further deterioration in renal function. Poor control of hyperphosphataemia suppresses the remaining endogenous la-hydroxylase and promotes ectopic calcification. Parathyroid tissue from uraemic subjects with secondary hyperparathyroidism has been shown, in vitro, to have an increased 'set point' (the extracellular calcium concentration at which 501170 maximal PTH secretion is observed)." Deficiency of calcitriol may have contributed to this but it appears that the number of calcitriol receptors in parathyroid tissue is reduced in renal failure. 82 In many patients, in spite of appropriate treatment, PTH secretion becomes autonomous and tertiary hyperparathyroidism ensues, eventually requiring parathyroidectomy (Fig. 6) .
The recognition that deficient calcitriol feedback inhibition of PTH production may be a very key pathogenic mechanism has led to the successful use of intermittent intravenous calcitriol infusion."
Involutional osteoporosis
Riggs and Melton'" have classified involutional osteoporosis into two types: type I (postmenopausal) and type II (senile). Low calcitriol levels have been suggested to playa part in both. In type I, oestrogen lack could raise extracellular calcium which would suppress PTH production,
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which in turn reduces calcitriol production. In type II, the reduction in the renal lo-hydroxylase activity with age could be responsible for the diminished production of calcitriol.84
Inherited forms of rickets or osteomalacia (Table 2) For simplicity these can be subdivided into six 'main' groups: A low serum phosphate is common to many of these disorders; it may be the primary pathological event or result from secondary hyperparathyroidism. There is some inconsistency in the literature, especially in the use of the terms 'resistant' and 'dependent'.
The hypophosphataemic syndrome (vitamin D resistant rickets). The X-linked dominant form
is the commonest form and presents in early infancy or childhood. Amongst the other biochemical abnormalities calcitriollevels may be low. An X-linked hypophosphataemic syndrome has been described in two mouse models (hyprnice and gyromice) and these have helped in elucidating the mechanism of renal handling of phosphate and in locating the hypophosphataernic gene. In humans, restriction fragment length polymorphism (RFLP) analysis has shown the gene to be located in the short arm of the X chromosome." An autosomally dominant form has also been described; this may present as non-rachitic hypophosphataemic bone disease (HBD) or as hypophosphataemic rickets (ADHR).85 Early child-
Hereditary hypophosphataemic rickets with

Infancy
Early infancy
age in acquired inability to maintain the hydrogen ion gradient between the tubular cell and lumen. Multiple biochemical abnormalities are present, including hypophosphataemia, and nephrocalcinosis may occur. The development of osteomalacia is a recognized feature, though the mechanism . remains unclear.
Pseudo vitamin deficiency rickets (PDDR). This autosomal recessively inherited disorder was formerly known as vitamin D dependent rickets type I. PDDR is due to deficiency of Io-hydroxylase and presents as classical rickets"
Hereditary vitamin D resistant rickets (HVDDR). In hypocalcaemic vitamin D resistant rickets (formerly known as vitamin D dependent rickets type II) there is end-organ resistance to calcitriol and therefore calcitriol levels are markedly raised." Inheritance is autosomal recessive. Alopecia totalis may occur. 87 Two of the earlier kindreds described were shown in each instance to be due to a single point mutation at the tip of a 'zinc finger' of VDR.8 8 Since these 'zinc fingers' are important in VDR binding to DNA, these mutations cause VDR to have a reduced affinity for DNA but to bind calcitriol normally." Several other mutations have now been described."
Oncogenous osteomalacia
Osteomalacia accompanied by hypophosphataemia and low ca1citriollevels has been associated with large mesenchymal and other tumours. This responds to either removal of the tumours or replacement with calcitriol.90
Hypervitaminosis D Hypervitaminosis D from excessive cutaneous production of cholecalciferol is unknown in normal individuals, but the seasonally increased levelsof ca1cidiol in the summer may be important in the pathogenesis of the hypercalciuria and hypercalcaemia of sarcoidosis." Hypervitaminosis D with resulting raised ca1cidiollevels is most commonly due to excessive oral ingestion, either self-administered'" or, more commonly, induced iatrogenically.W" Administration of calciferol can result in a protracted hypercalcaemia," and sometimes levels may continue to rise even after medication has been discontinued." This has led to the utilization of enzyme-inducing drugs to increase the elimination rate of vitamin D. 97,98 Treatment with the active metabolites of vitamin D does not cause this problem, as they are cleared endogenously much faster.P? They Vitamin D metabolism and metabolites 117 are, however, capable of causing significant hypercalcaemia.
There is selective overproduction of calcitriol in sarcoidosis?' and other granulomatous conditions, lymphoid malignancy.P" idiopathic hypercalciuria and tumoral calcinosis .101,102 Plasma calcitriol, calcidiol and ergocalciferol levels can all be raised in ergocalciferol poisoning. 96 ,103
CLINICAL ASPECTS OF VITAMIN D METABOLITE MEASUREMENT
Of the many metabolites of vitamin D, calcidiol and calcitriol concentrations in serum are widest in use in assessing the clinical disturbances of vitamin D metabolism.
Calcidiol [25(OH)VitDj
The commonest requirement is for measurement of serum calcidiol concentration to assess 'nutritional' status and for the diagnosis of privational vitamin D deficiency. Many comparisons have been made of calcidiol with other investigative measures of vitamin D deficiency including serum concentrations of adjusted calcium, phosphate, alkaline phosphatase activity and PTH as well as clinical scores and histological and radiological evidence of osteomalacia. 56,104,105 Although serum alkaline phosphatase activity and PTH measurements have been reported to be useful in identifying histological osteomalacia,56,106 calcidiol concentrations have been reported to be misleading'?' and non-discriminatory between histologically normal, borderline and osteomalacia subgroups. 56 Low concentrations of calcidiol have been reported in patients without histological osteomalacia'v-P' and conversely, normal values have been found in patients with histologically proven osteomalacia.P? There may be a number of reasons why calcidiollevels have shown poor correlation with histological and other investigative measures.
The presence of" histological osteomalacia reflects a certain severity of vitamin D deficiency. Changes in all investigative measures are unlikely to parallel each other since they manifest a sequence of pathological and compensated homeostatic mechanisms. As vitamin D deficiency is the prime' event, calcidiol concentrations are likely to alter first. Other causes which may alter calcidiol relatively quickly include; seasonal variation in vitamin D deficiency, 110 hospitalization'!' (calcidiollevels may rise within days of Iqbal hospital admission) and self-administration of easily obtainable vitamin D preparations. 56 Significant analytical variability may add to the difficulty of interpreting calcidiol concentrations. All these factors have led to the difficulty of relating calcidiol concentrations to histological osteomalacia. III However, if deficiency becomes extreme, calcidiol concentrations are more likely to correlate with other diagnostic measures. 105, 112 When calcidiol becomes undetectable histological osteomalacia is more consistently seen (unpublished observations). Following treatment, calcidiol concentrations are again likely to alter frrst ll3,114 as histological changes'!' and abnormal PTH secretion may persist for rnonths.F' Indeed, the alkaline phosphatase activity may even rise initially. 116 The inconsistent use of the term 'vitamin D deficiency' by different workers, and the difficulties of what measures best define it have been discussed."?
Measurement of calcidiol concentration is useful in assessing vitamin D status due to malabsorption and has been used for nutritional surveys in Asians!" and the elderly.118,119 Measurement of serum calcidiol has also been useful in assessing the therapeutic response to oral and parenteral dosage regimes,120-122 in both privational deficiency and malabsorption. Some instances where measurements of calcidiollevels may be helpful are listed in Table 3 . Vitamin D metabolites circulate largely bound to plasma proteins. Variation in the concentration of binding protein may thus alter the total levels without changing the level of free metabolite. It is the free concentration which determines the cellular response.F' Of calcidiol and calcitriol 85-880/0 is bound to DBP and 12-15% to albumin. Of calcidiol 0.030/0 and of calcitriol 0.4% is free. 123 The level of DBP is influenced by steroids, especially by oestrogen (of particular relevance during pregnancy when both free and total calcidiol concentrations may be elevated) and may be low in the nephrotic syndrome. 124 ,125 An index of free calcidiol derived by saturation analysis l26 has been described and free metabolite levels have been determined directly by centrifugal ultrafiltration.!" Although most subjects with severe liver disease have lower total calcidiol levels, both free calcidiol and free calcitriol are normal, which explains the lack of osteomalacia in such patients. 123, 127 Markedly raised levels of calcidiol are indicative of excessive intake. In unexplained causes of hypercalcaemia, raised levels of calcidiol have proved to be diagnostic of vitamin D intoxication in surreptitious intake.P" in excessive industrial exposure'P and in cases of vitamin D poisoning where several family members have been intoxicated due to unidentified presumed vitamin D fortified foodstuffs. 92. l3 o Calcitriol [1, 25(OHhVitD] The increasing recognition of the central importance of calcitriol as the active hormone has led to its measurement in a number of clinical situations. In many instances this has been the key to understanding the underlying pathophysiology, as in sarcoidosis and HVDRR. However, the complexity of some of the assays, and therefore the lack of routine availability, has probably been the reason for the surprising small amount of data available on plasma concentrations in, for example, chronic renal failure. Where measurements have been made, high normal, normal and low levels have all been reported in chronic renal failure. 13l, 132 Poor analytical performance at the lower end of the reference range may have been responsible for some of the variability. A recent review recognised that early replacement with la analogues would be the key to controlling bone disease in CRF, but plasma levels of calcitriol were stated not to be a useful guide for initiating therapy.P?
Thus, the value of measuring calcitriol levels routinely in chronic renal failure is unproven. The sheer volume of work this would generate, and the technical difficulty of some of the assays, means routine measurement of calcitriol in chronic renal failure cannot be recommended at present.
In other clinical circumstances incorrect interpretation has led to clinical confusion. In the early phase of treatment of nutritional vitamin D deficiency, calcitriollevels may change rapidly to supraphysiological concentrations.Pt-P' Diagnostic investigations have been described where there is modulation of plasma calcitriol levels; stimulation by infused PTH and suppression with calcium loads.!" Apart from their limited use in some patients with chronic renal failure 132 and in elderly patients with declining kidney function 136 they seem to have been little studied.
Qualit}· assurance of vitamin D metabolite measurements
Since the development of the first useful competitive protein binding assay for 25(OH)VitD a variety of methods have been published and reviewed. 137, 138 In many of these methods the reliability of the assay has been inadequately assessed. One international interlaboratory comparison for calcidiol involving 15 laboratories showed that all laboratories could distinguish between grossly increased and normal concentrations but eight of the 15 could not distinguish between normal and low levels.P? In a UK survey of 12 laboratories, a coefficient of variation (CV) of 630/0 was found at the distribution with lowest concentration.P? Although a resurvey showed much improvement, this was only for two distributions with higher concentrations. In this survey inconsistent standard calibration also contributed to the poor performance. 140 In a survey which included assessment of calcitriollevels, only eight of the 15 laboratories were able to distinguish between modified and unmodified samples, suggesting that important physiological changes could not be picked Up. 141 In a further survey of calcitriol, the interlaboratory CVs were 20% in normal subjects and pregnant women and 54% in patients with chronic renal failure. 142
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It is clear, therefore, that results obtained from different laboratories should be compared with great caution. A recent review has pointed out the need for improvement in both precision and accuracy. The values of participation in quality assurance was also emphasized.!" An external quality assessment scheme for calcidiol is available.r" but it is not known whether such a scheme exists for calcitriol.
Conclusions on measurement of 2S(OH)VitD and 1,2S(OHh VitD
The frequency of disorders of vitamin D metabolism provide clinical justification for the availability of assays for two of the major vitamin D metabolites (calcidiol and calcitriol). Some of the clinical indications for the measurements of these metabolites are indicated in Table 3 .
Calcidiol levels could be useful in a District General Hospital which services a large elderly or Asian population. However, measurement of calcidiol and calcitriol concentration should ideally be available in tertiary centres or research laboratories where assay reliability has been thoroughly assessed and such centres participate in external quality assessment schemes. 
